Author:
Gazioglu Isil,Evrim Kepekci Tekkeli S.,Tartaglia Angela,Aslan Ceylin,Locatelli Marcello,Kabir Abuzar
Subject
Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry
Reference34 articles.
1. American Society of Health-System Pharmacists;Manasse;Pharmacotherapy,2001
2. The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial;Becker;Arthritis Res. Ther.,2010
3. E. Roddy, M. Doherty, Epidemiology of gout, Arthritis Res. Ther. 12(6) (2010) article 223, 1-11.
4. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial;Mackenzie;Lancet,2020
5. Failure to reach uric acid target of < 0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality;Ruiz;RMD Open,2019
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献